Summary of presentationPromoting the use of generic drugs is a key for reducing public medical expenditure. In Japan, the government implemented a reform of medical prescription form in April 2008. Before the reform, pharmacists were not allowed to replace a brand-named drug prescribed with a generic alternative without doctors’ permission. After the reform, pharmacists were now allowed to replace unless doctors’ stating otherwise in the prescription form. Using a large scale medical prescription record from Japanese public hospitals 2006-2009, we found that the reform increased the rate of generic drug prescription by about 8%. The implications of the study are the following: 1) the effect of a “choice architecture” can be sustainable at population level; 2) a choice architecture can change professionals’ behavior; 3) promotion of the use of generic drugs can be achieved without using major regulations or economic incentives.
|Date and time||September 30th (Fri), 2016 16:30-18:00|
|Venue||Hitotsubashi University, Mercury Tower 3F #3302|
|Speaker||Ryota NAKAMUR, Research Fellow, Center for Health Economics, University of York, UK|
(The affiliation will be untl September 30. From October 1st he will be an associate professor of Hitotsubashi Institute for Advanced Study, Hitotsubashi University.)
|Title||Impact of a `choice architecture’ on medical prescription in Japanese national health insurance system|
|Language||Presentation will be given in English.|